Literature DB >> 2848708

A possible drug interaction between rifampicin and enalapril.

D Kandiah1, W J Penny, A G Fraser, M J Lewis.   

Abstract

When a 35-year-old man with essential hypertension was treated with antibiotics for brucellosis his blood pressure rose significantly. While all other treatment was kept constant rifampicin was discontinued. On rechallenge rifampicin did not alter serum concentrations of enalapril or the area under the curve (AUC) between 0 and 7 h, but it did reduce the AUC of the active metabolite enalaprilat by 31%. These observations suggest that there may be an interaction between rifampicin and enalapril, causing reduced hypotensive efficacy of enalapril. The mechanism of such an interaction merits further study, but it could be due to enhanced renal clearance of enalaprilat.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848708     DOI: 10.1007/bf00561378

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  2 in total

1.  Effect of enzyme induction on plasma lipids using antipyrine, phenobarbital, and rifampicin.

Authors:  E E Ohnhaus; B Kirchhof; E Peheim
Journal:  Clin Pharmacol Ther       Date:  1979-05       Impact factor: 6.875

2.  Enalapril maleate (MK-421), a potent, nonsulfhydryl angiotensin-converting enzyme inhibitor: absorption, disposition, and metabolism in man.

Authors:  E H Ulm
Journal:  Drug Metab Rev       Date:  1983       Impact factor: 4.518

  2 in total
  7 in total

Review 1.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 2.  Fosinopril. Clinical pharmacokinetics and clinical potential.

Authors:  H Shionoiri; M Naruse; K Minamisawa; S Ueda; H Himeno; S Hiroto; I Takasaki
Journal:  Clin Pharmacokinet       Date:  1997-06       Impact factor: 6.447

Review 3.  Pharmacokinetic interactions with rifampicin : clinical relevance.

Authors:  Mikko Niemi; Janne T Backman; Martin F Fromm; Pertti J Neuvonen; Kari T Kivistö
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 4.  Pharmacokinetic drug interactions with ACE inhibitors.

Authors:  H Shionoiri
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

Review 5.  Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

Review 6.  Metabolites of antihypertensive drugs. An updated review of their clinical pharmacokinetic and therapeutic implications.

Authors:  A Ebihara; A Fujimura
Journal:  Clin Pharmacokinet       Date:  1991-11       Impact factor: 6.447

7.  Temporal changes in physiological and molecular markers in various brain regions following transient global ischemia in rats.

Authors:  Monika Kapoor; Sheetal Sharma; Rajat Sandhir; Bimla Nehru
Journal:  Mol Biol Rep       Date:  2019-09-07       Impact factor: 2.316

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.